Literature DB >> 15872083

Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease.

Katherine R Tuttle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872083     DOI: 10.1681/ASN.2005040393

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  70 in total

1.  Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy.

Authors:  Qingjuan Liu; Lingling Xing; Lei Wang; Fang Yao; Shuxia Liu; Jun Hao; Wei Liu; Huijun Duan
Journal:  J Histochem Cytochem       Date:  2013-11-11       Impact factor: 2.479

2.  Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.

Authors:  Zhigang Wang; Meng Wei; Meng Wang; Lei Chen; Hua Liu; Yi Ren; Kehui Shi; Hongli Jiang
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 3.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Authors:  Raimund Pichler; Maryam Afkarian; Brad P Dieter; Katherine R Tuttle
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

4.  Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.

Authors:  Jia Fu; Kemal M Akat; Zeguo Sun; Weijia Zhang; Detlef Schlondorff; Zhihong Liu; Thomas Tuschl; Kyung Lee; John Cijiang He
Journal:  J Am Soc Nephrol       Date:  2019-03-07       Impact factor: 10.121

5.  Schisandrin C attenuates renal damage in diabetic nephropathy by regulating macrophage polarization.

Authors:  Yu Wang; Jingqiu Cui; Ming Liu; Yingqi Shao; Xiaoying Dong
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

6.  Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy.

Authors:  Mingao Wang; Rujuan Xie; Ruichan Liu; Xibei Jia; Yushi Bao; Xiaomin Liu
Journal:  Endocrine       Date:  2012-03-07       Impact factor: 3.633

7.  C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes.

Authors:  F Liu; H Y Chen; X R Huang; A C K Chung; L Zhou; P Fu; A J Szalai; H Y Lan
Journal:  Diabetologia       Date:  2011-07-09       Impact factor: 10.122

Review 8.  Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases.

Authors:  Jingping Hu; Mao Ye; Zhiguang Zhou
Journal:  J Mol Med (Berl)       Date:  2016-11-15       Impact factor: 4.599

9.  The effects of ozone therapy on caspase pathways, TNF-α, and HIF-1α in diabetic nephropathy.

Authors:  Aydın Güçlü; Haydar Ali Erken; Gülten Erken; Yavuz Dodurga; Arzu Yay; Özge Özçoban; Hasan Şimşek; Aydın Akçılar; Fatma Emel Koçak
Journal:  Int Urol Nephrol       Date:  2015-11-27       Impact factor: 2.370

10.  The effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat.

Authors:  Carolyn M Ecelbarger; Arjun Rash; Rajesh K Sinha; Swasti Tiwari
Journal:  Mediators Inflamm       Date:  2010-05-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.